CollPlant Biotechnologies Board Approves 1-For-10 Reverse Share Split, Effective September 4

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten reverse share split of the Company's ordinary shares. The reverse share split is scheduled to take effect when the Nasdaq Capital Market opens on September 4, 2026, at which point the Company's ordinary shares will begin trading on a split-adjusted basis under the existing ticker symbol "CLGN". The Board's decision follows shareholder approval granted at the Extraordinary General Meeting of Shareholders held on August 18, 2026. The reverse split is being implemented as part of the Company's strategic plan to regain compliance with the Nasdaq minimum bid price requirement for continued listing.